Julie D. Klapstein - May 2, 2023 Form 4 Insider Report for Oak Street Health, Inc. (OSH)

Role
Director
Signature
/s/ Robert Guenthner, attorney-in-fact for Julie Klapstein
Stock symbol
OSH
Transactions as of
May 2, 2023
Transactions value $
-$1,235,676
Form type
4
Date filed
5/2/2023, 07:53 PM
Previous filing
Apr 28, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSH Common stock, $0.001 par value Disposed to Issuer -$1.24M -31.7K -100% $39.00 0 May 2, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Julie D. Klapstein is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to that certain Agreement and Plan of Merger, dated as of February 7, 2023 (the "Merger Agreement"), by and among the Issuer, CVS Pharmacy, Inc. ("Parent"), Halo Merger Sub Corp. ("Merger Sub") and, for the limited purposes set forth therein, CVS Health Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $39.00 per share in cash, without interest and subject to applicable tax withholdings (the "Per Share Price").
F2 (Continued from Footnote 1) The shares of the Issuer's common stock reported as disposed by the Reporting Person include vested restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically canceled and converted into the right to receive an amount in cash (without interest and subject to applicable tax withholdings) equal to the product of the Per Share Price multiplied by the number of shares of the Issuer's common stock subject to such RSUs as of immediately prior to the Effective Time.
F3 The shares of the Issuer's common stock reported as disposed on this Form 4 reflects a correction to the Reporting Person's Form 4 filed on April 25, 2023, which incorrectly reported 50,912 shares of the Issuer's common stock as beneficially owned by the Reporting Person following the reported transaction instead of the correct amount of 31,684 shares of the Issuer's common stock.